- Home
- CDIO
as 06-06-2025 2:32pm EST
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 7.0M | IPO Year: | N/A |
| Target Price: | $60.00 | AVG Volume (30 days): | 114.4K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.40 - $53.10 | Next Earning Date: | 05-15-2025 |
| Revenue: | $19,902 | Revenue Growth: | -39.68% |
| Revenue Growth (this year): | 1434.82% | Revenue Growth (next year): | 4661.90% |
Latest Cardio Diagnostics Holdings Inc. Common stock News
CDIO Breaking Stock News: Dive into CDIO Ticker-Specific Updates for Smart Investing
Business Wire
8 days ago
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price
Business Wire
17 days ago
Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico
Simply Wall St.
20 days ago
Cardio Diagnostics Holdings First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Business Wire
a month ago
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
Business Wire
2 months ago
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session
Simply Wall St.
2 months ago
Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Insider Monkey
3 months ago
Is Cardio Diagnostics Holdings, Inc. (CDIO) The Best Day Trading Stock To Invest In Now?
Insider Monkey
4 months ago
Cardio Diagnostics Holdings, Inc. (CDIO) Expands AI-Driven Heart Disease Testing with 7 New Partnerships
Compare CDIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDIO Cardio Diagnostics Holdings Inc. Common stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.